Compugen Ltd.
Status: Publicly traded
Direct answer
Compugen Ltd. is publicly traded on NASDAQ under the ticker CGEN.
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe. The company’s core activities center around its immuno-oncology pipeline, which includes several investigational treatments: COM701,...
Can you invest in Compugen Ltd.?
Yes. Compugen Ltd. trades publicly on NASDAQ as CGEN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Compugen Ltd.
Detailed equity research is provided by MarketSnap.